Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma

被引：16

作者：

Gomez-Hidalgo, Natalia R. ^{[1
]}

Chen, Ling ^{[1
]}

Hou, June Y. ^{[1
,4
,5
]}

Tergas, Ana, I ^{[1
,3
,4
,5
]}

St Clair, Caryn M. ^{[1
,4
,5
]}

Ananth, Cande, V ^{[1
,3
]}

Hershnnan, Dawn L. ^{[2
,3
,4
,5
]}

Wright, Jason D. ^{[1
,4
,5
]}

机构：

[1] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA

[2] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA

[3] Columbia Univ, Dept Epidemiol, Joseph L Mailman Sch Publ Hlth, New York, NY USA

[4] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA

[5] New York Presbyterian Hosp, New York, NY USA

来源：

CANCER INVESTIGATION | 2018年 / 36卷 / 03期

关键词：

Uterine cancer; Endometrial cancer; Sentinel lymph node; Lymphadenectomy; Hysterectomy; SYSTEMATIC PELVIC LYMPHADENECTOMY; UTERINE-CANCER; ALGORITHM;

D O I：

10.1080/07357907.2018.1449212

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We analyzed 54,039 women with uterine cancer in the National Cancer Database from 2013 to 2014 including 38,453 (71.2%) who underwent lymphadenectomy, 1929 (3.6%) who underwent sentinel lymph node (SLN) mapping, and 13,657 (25.3%) who did not undergo nodal assessment. SLN mapping increased from 2.8% in 2013 to 4.3% in 2014 (P < 0.001). Patients treated in 2014 and those at community centers were more likely to undergo SLN biopsy, while women with advanced-stage disease, sarcomas, and grade 3 tumors were less likely to undergo SLN mapping (P < 0.05). There was no association between use of SLN biopsy and use of radiation (aRR = 0.92; 95% CI, 0.82-1.05).

引用

页码：190 / 198

页数：9

共 50 条

[1] The role of sentinel lymph node mapping in endometrial carcinoma
Soderini, Alejandro
Depietri, Valeria
Crespe, Martin
Rodriguez, Yanina
Aragona, Alejandro
MINERVA GINECOLOGICA, 2020, 72 (06): : 367 - 383
[2] The progress and prospect of sentinel lymph node mapping in endometrial carcinoma
Shi, Jiayan
Shi, Zhixian
Chen, Qianrun
Bian, Ce
FRONTIERS IN MEDICINE, 2023, 10
[3] V-NOTES sentinel lymph node mapping for endometrial carcinoma
Erkilinc, Selcuk
Cakir, Ilker
Ozturk, Ayse Betul
Ozcan, Sena
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A58 - A58
[4] Sentinel Lymph Node Mapping in Patients with Endometrial Carcinoma: Less Can Be More
Leitao M.M., Jr.
Current Obstetrics and Gynecology Reports, 2016, 5 (4) : 279 - 285
[5] Sentinel lymph node in apparent early-stage endometrial carcinoma: its impact on the adjuvant therapy decision
Guilmi, Julian Di
Perez, Jorge
Luna, Johana Quiroga
Maya, Antonio
Darin, Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A162 - A162
[6] Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping
Praiss, Aaron M.
Dagher, Christian
Zhou, Qin
Iasonos, Alexia
Rios-Doria, Eric
Abu-Rustum, Nadeem R.
Chiang, Sarah
Momeni-Boroujeni, Amir
Weigelt, Britta
Ellenson, Lora H.
Leitao Jr, Mario M.
Mueller, Jennifer J.
GYNECOLOGIC ONCOLOGY, 2024, 191 : 37 - 44
[7] Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma
Caryn M. St. Clair
Ane Gerda Z. Eriksson
Jennifer A. Ducie
Elizabeth L. Jewell
Kaled M. Alektiar
Martee L. Hensley
Robert A. Soslow
Nadeem R. Abu-Rustum
Mario M. Leitao
Annals of Surgical Oncology, 2016, 23 : 1653 - 1659
[8] Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma
St Clair, Caryn M.
Eriksson, Ane Gerda Z.
Ducie, Jennifer A.
Jewell, Elizabeth L.
Alektiar, Kaled M.
Hensley, Martee L.
Soslow, Robert A.
Abu-Rustum, Nadeem R.
Leitao, Mario M., Jr.
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) : 1653 - 1659
[9] Sentinel-lymph-node mapping in endometrial cancer
Bogani, Giorgio
Ditto, Antonino
Maggiore, Umberto Leone Roberti
Lorusso, Domenica
Raspagliesi, Francesco
LANCET ONCOLOGY, 2017, 18 (05): : E234 - E234
[10] Trends in performance of sentinel lymph node mapping and its association with use of adjuvant therapy for women with uterine cancer
Gomez-Hidalgo, N. R.
Chen, L.
Hou, J. Y.
Tergas, A. I.
St Clair, C.
Ananth, C. V.
Hershman, D. L.
Wright, J. D.
GYNECOLOGIC ONCOLOGY, 2018, 149 : 199 - 199

← 1 2 3 4 5 →